Do NOT Administer Radiation Before Hip Surgery
For patients with localized, non-high-risk prostate cancer requiring hip surgery, you should perform the hip surgery first and defer prostate cancer radiation therapy until after orthopedic recovery. There is no clinical indication to reverse this sequence, and doing so would unnecessarily delay needed orthopedic intervention without oncologic benefit.
Rationale for Hip Surgery First
Oncologic Timeline Considerations
- Localized, non-high-risk prostate cancer typically has an indolent natural history that allows for delayed definitive treatment without compromising cancer outcomes
- Hip surgery addresses an immediate functional impairment and quality of life issue that requires prompt intervention
- The AUA/ASTRO guidelines 1 emphasize that prostate cancer management is "preference-sensitive" and based on balancing treatment-specific risks and benefits—delaying radiation by weeks to months for hip surgery recovery does not compromise cancer control in non-high-risk disease
Technical and Safety Concerns with Pre-existing Hip Prostheses
If you were to perform radiation after hip replacement (which would occur if you did hip surgery first), you face these challenges:
Increased toxicity risk: A 2024 study of SBRT in patients with pre-existing hip prostheses showed concerning rates of late Grade ≥3 GU toxicity (8.6%) and Grade ≥2 GI toxicity (4.3%), with a 26% local recurrence rate at median 7-year follow-up 2. These rates substantially exceed expected outcomes in the general population.
Imaging artifacts: Metal hip prostheses create significant CT and MRI artifacts that distort target delineation and dose calculations 2, 3. While modern IMRT and VMAT techniques can partially compensate 3, 4, the technical challenges remain substantial.
Beam arrangement limitations: Treatment planning must avoid beams that directly traverse the prosthesis 4, 5, which constrains optimal beam geometry and may compromise target coverage or increase normal tissue doses.
However, a 2022 study showed that with careful VMAT planning, toxicity rates in patients with bilateral hip prostheses were not significantly different from controls (31% vs 14% late Grade ≥2 GI toxicity, p=0.14) 3, suggesting modern techniques can mitigate but not eliminate these concerns.
The Correct Clinical Sequence
- Perform hip surgery first to address the immediate functional impairment
- Allow adequate orthopedic recovery (typically 6-12 weeks)
- Initiate prostate cancer radiation therapy once the patient has recovered sufficient mobility and can tolerate treatment positioning
Important Caveats
If the patient has high-risk prostate cancer features (not specified in your question), the calculus changes—oncologic urgency may warrant prioritizing radiation or considering alternative approaches like brachytherapy, which uses ultrasound guidance and avoids CT/MRI artifact issues 2.
Heterotopic ossification prophylaxis: If radiation is given preoperatively for any reason, note that single-fraction 7 Gy within 4 hours before hip surgery effectively prevents heterotopic ossification 6—but this is a completely different indication and dose than therapeutic prostate radiation.
Post-hip arthroplasty radiation considerations: Patients with prior radiation have increased odds of THA complications including prosthetic joint infection, periprosthetic fracture, and aseptic loosening 7. However, this addresses radiation before THA, not the reverse sequence you're asking about.
Bottom Line
Proceed with hip surgery without delay, then address the prostate cancer with radiation after orthopedic recovery. The non-high-risk prostate cancer can safely wait, the hip cannot, and performing radiation after hip replacement—while technically challenging—is feasible with modern techniques and appropriate patient counseling about potentially elevated toxicity risks 2, 3.